CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $105 | $100 | $108 |
Gross Profit | 98 | 93 | 97 |
EBITDA | -804 | -761 | -512 |
EBIT | -874 | -828 | -576 |
Net Income | -882 | -835 | -555 |
Net Change In Cash | 105 | 100 | 108 |
Free Cash Flow | -765 | -724 | -795 |
Cash | 2,245 | 2,125 | 3,867 |
Basic Shares | 11,809 | 11,809 | 11,540 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $52 | $290 | $270 | $84 |
Gross Profit | 52 | 381 | -81 | 81 |
EBITDA | -1,790 | -2,937 | -1,095 | -1,047 |
EBIT | -1,882 | -3,015 | -1,388 | -1,291 |
Net Income | -1,883 | -3,131 | -2,270 | -1,533 |
Net Change In Cash | 52 | 290 | 270 | 84 |
Free Cash Flow | -3,009 | -2,720 | -1,397 | -1,701 |
Cash | 3,639 | 6,816 | 1,179 | 1,863 |
Basic Shares | 11,539 | 10,630 | 7,915 | 6,934 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-03-31 | -$0.12 |
2024-09-30 | -$0.04 |
2024-06-30 | -$0.09 |
